Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Oct 25 (Reuters) - French drug maker Sanofi (SASY.PA), opens new tab on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than ...

The consumer business also agreed to keep its headquarters in the country. Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months.

Economy Minister Antoine Armand said a contract between CD&R, Sanofi and the government included maintaining production sites, research and development and Opella's official headquarters in France ...

The consumer business also agreed to keep its headquarters in the country. Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months. Despite ...